Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
619,506
+421,184
+212% +$1.86M ﹤0.01% 2460
2026
Q1
$716K Buy
198,322
+148,374
+297% +$513K ﹤0.01% 2951
2025
Q4
$170K Sell
49,948
-38,976
-44% -$189K ﹤0.01% 3389
2025
Q3
$604K Sell
88,924
-8,830
-9% -$72.9K ﹤0.01% 2714
2025
Q2
$1.33M Sell
97,754
-87,883
-47% -$830K ﹤0.01% 2027
2025
Q1
$1.01M Sell
185,637
-78,216
-30% -$444K ﹤0.01% 2012
2024
Q4
$1.31M Sell
263,853
-423,427
-62% -$2.22M ﹤0.01% 1749
2024
Q3
$3.6M Buy
+687,280
New +$3.96M 0.01% 1208

Other funds holding LFMD

Cliff Asness's LFMD Position: Q2 2026 in Review

Cliff Asness increased its LifeMD (LFMD) stake by 212% in Q2 2026, buying an estimated $1.86M and bringing the position to 619,506 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2460.

Cliff Asness first reported a position in LFMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.6M in Q3 2024. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Cliff Asness held 619,506 shares of LifeMD worth $2.56M as of Q2 2026.
  • Cliff Asness bought 421,184 LifeMD shares in Q2 2026, an estimated $1.86M.
  • LifeMD made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2460 holding.
  • Cliff Asness first reported a position in LifeMD in Q3 2024 and has held it in 8 quarters since.
  • Cliff Asness's LifeMD position peaked at $3.6M in Q3 2024.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.